NIH Human Embryonic Stem Cell Registry

Detailed information for selected cell line:

Cell Line: HS799; Huntington's disease mutation
NIH Registration Number: 0207
NIH Approval Number: NIHhESC-13-0207
Available for Distribution: Yes - Through Stockholm Medical Biobank when a valid Material Transfer Agreement (MTA) exists.
Provider Restrictions: 1. An ethical approval by the Swedish Ethical Review Authority and agreement that regulates the existing research project´s access to Healthcare Principal´s Biobank (Biobank Agreement) is required in order to set up a Material Transfer Agreement (MTA). 2. The human biological samples can be sent outside Sweden from a Swedish biobank by a responsible Research Principal who intends to use the samples (material) for analyses as part of a research project that has been approved by the Swedish Ethical Review Authority. 3. When the planned analysis is finished, the samples should be either completely consumed during analyses, destroyed after the analyses, or returned back.

Additional Information: Line was derived from an embryo with mutations causing Huntington's disease.

NIH Restrictions: (No Additional Restrictions)
Submitting Organization: Karolinska Institute
Provider Name: Stockholm Medical Biobank; Biobank number (IVO):914 (formerly Karolinska Institute)
Provider Phone: +46 8-517 725 52
Provider Email: biobankstockholm@regionstockholm.se; Fredrik.Lanner@ki.se; Ganesh.Acharya@ki.se
Provider URL: https://biobankstockholm.se
Approval Date: 03/18/2013


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on September 25, 2022 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster